End-of-day quote
Shenzhen S.E.
23:00:00 12/05/2024 BST
5-day change
1st Jan Change
7.22
CNY
-2.83%
+5.09%
-29.90%
Guangdong Biolight Meditech Co., Ltd. Reports Earnings Results for the Full Year Ended December 31, 2021
April 25, 2022 at 03:48 pm
Guangdong Biolight Meditech Co., Ltd. reported earnings results for the full year ended December 31, 2021. For the full year, the company reported sales was CNY 1,074.28 million compared to CNY 1,385.63 million a year ago. Revenue was CNY 1,091.02 million compared to CNY 1,396.01 million a year ago. Net income was CNY 63.79 million compared to CNY 346.15 million a year ago. Basic earnings per share from continuing operations was CNY 0.4367 compared to CNY 2.3694 a year ago. Diluted earnings per share from continuing operations was CNY 0.4367 compared to CNY 2.3632 a year ago.
Guangdong Biolight Meditech Co., Ltd. Reports Earnings Results for the First Quarter Ended March 31, 2024
04-24
CI
Guangdong Biolight Meditech Co., Ltd. Reports Earnings Results for the Full Year Ended December 31, 2023
04-23
CI
Tranche Update on Guangdong Biolight Meditech Co., Ltd.'s Equity Buyback Plan announced on February 7, 2024.
04-01
CI
Guangdong Biolight Meditech Co., Ltd. announces an Equity Buyback for CNY 30 million worth of its shares.
02-07
CI
Guangdong Biolight Meditech Co., Ltd. authorizes a Buyback Plan.
02-06
CI
Guangdong Biolight Meditech Co., Ltd. Reports Earnings Results for the Nine Months Ended September 30, 2023
26/10/23
CI
Guangdong Biolight Meditech Co., Ltd. Reports Earnings Results for the Half Year Ended June 30, 2023
27/07/23
CI
Guangdong Biolight Meditech Co., Ltd. Reports Earnings Results for the First Quarter Ended March 31, 2023
18/04/23
CI
Guangdong Biolight Meditech Co., Ltd. Reports Earnings Results for the Full Year Ended December 31, 2022
18/04/23
CI
Guangdong Biolight Meditech Co., Ltd. Approves Executive Elections
27/12/22
CI
Guangdong Biolight Meditech Co., Ltd. entered into an agreement to acquire 51% stake in Sanyuan Fusheng Medical Devices Co., Ltd from Shaanxi Fusheng Medical Products Co., Ltd. for CNY 6.5 million.
08/12/22
CI
Guangdong Biolight Meditech Co., Ltd. Reports Earnings Results for the Nine Months Ended September 30, 2022
27/10/22
CI
Shenzhen Baoyuan Medical Devices Co., Ltd. announced that it has received CNY 25 million in funding from Guangdong Biolight Meditech Co., Ltd.
05/09/22
CI
Guangdong Biolight Meditech Co., Ltd. Reports Earnings Results for the Half Year Ended June 30, 2022
29/08/22
CI
Shenzhen Baoyuan Medical Devices Co., Ltd. announced that it expects to receive CNY 25 million in funding from Guangdong Biolight Meditech Co., Ltd.
30/05/22
CI
Guangdong Biolight Meditech Co., Ltd. Reports Earnings Results for the First Quarter Ended March 31, 2022
28/04/22
CI
Guangdong Biolight Meditech Co., Ltd. Reports Earnings Results for the Full Year Ended December 31, 2021
25/04/22
CI
Medical Devices Maker Biolight Raises $83 Million From Share Placement
17/02/22
MT
Guangdong Biolight Meditech Co., Ltd. announced that it has received CNY 539.999995 million in funding from Sichuan Guojing Capital Holding Co., Ltd., UBS AG, China Asset Management Co., Ltd., CCB Principal Asset Management Co., Ltd. and other investors
24/01/22
CI
Guangdong Biolight Meditech Co., Ltd. Reports Earnings Results for the Half Year Ended June 30, 2021
29/08/21
CI
Nanchang Biolight Meditech Co., Ltd. announced that it expects to receive CNY 20 million in funding from Guangdong Biolight Meditech Co., Ltd.
26/08/21
CI
Guangdong Biolight Meditech Co., Ltd. Reports Earnings Results for the First Quarter Ended March 31, 2021
27/04/21
CI
Guangdong Biolight Meditech Co., Ltd. agreed to acquire remaining 38.44% stake in Suzhou Jun Kang Medical Technology Co., Ltd. from Suzhou Junying Industrial Investment Enterprise (Limited Partnership), Suzhou Junjian Industrial Investment Enterprise (Limited Partnership) and Hong Kong World Technology Limited for approximately CNY 110 million.
08/04/21
CI
Guangdong Biolight Meditech Co., Ltd. Reports Earnings Results for the Full Year Ended December 31, 2020
08/04/21
CI
Suzhou Jun Kang Medical Technology Co., Ltd. announced that it expects to receive CNY 100 million in funding from Guangdong Biolight Meditech Co., Ltd.
07/04/21
CI
Duration Auto. 2 months 3 months 6 months 9 months 1 year 2 years 5 years 10 years Max.
Period Day Week
More charts
GUANGDONG BIOLIGHT MEDITECH CO., LTD. is a China-based company principally engaged in the research, development, production and sales of medical monitoring equipment, hemodialysis products and ancillary products. Its medical monitoring equipment includes monitoring equipment, electrocardiograph, pulse oximeters and central monitoring systems. Its hemodialysis products include hemodialysis machines, hemodialyzers, hemodialysis powders/dialysates and perfusion machines. The Company distributes its products in domestic and overseas markets.
More about the company
+951% of historical performance
More than 20 years at your side
Our Experts are here for you
OUR EXPERTS ARE HERE FOR YOU
Monday - Friday 9am-12pm / 2pm-6pm GMT + 1